A new study to be presented at the SLEEP 2026 annual meeting found that women with moderate-to-severe obstructive sleep apnea ...

The AcuPebble, developed by Imperial spinout Acurable, promises easier access to a diagnosis and savings for the health service. A wearable medical device that tests for the breathing disorder ...

A new study to be presented at the SLEEP 2026 annual meeting found that patients at high risk for obstructive sleep apnea who ...

Moderate to severe obstructive sleep apnea (OSA) independently correlated with development of cerebral microbleeds seen on brain MRI that are linked to stroke and dementia risk, a longitudinal cohort ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...

Obstructive sleep apnea (OSA) can affect moods and stress through disrupted sleep, oxygen deprivation, and repeated activation of the body’s stress system. Recognizing and treating OSA can improve ...